Research
March 14, 2025
70 Years after Discovery, UAMS Myeloma Center, Castleman Disease Collaborative Network Lead the Way in Understanding Disease
By Frits van Rhee, M.D., Ph.D. Castleman disease was first described in 1954 by Benjamin Castleman, M.D., longtime chief of the Division of Anatomic Pathology at Massachusetts General Hospital in Boston. Patients with Castleman disease have enlargement of one or more lymph node areas. Patients who have the disease in one area, unicentric Castleman disease,…
Funding Awards Amplify Myeloma Research
At the UAMS Myeloma Center, Fenghuang (Frank) Zhan, M.D., Ph.D., knows that research plays an immensely important role in the fight against multiple myeloma. Numerous federal grants allow the center’s director of research and his team to continue to advance and improve treatments, benefitting myeloma patients around the world. The latest is a $1.1 million…
Myeloma Center Focuses on Immunotherapy Drugs in Latest Clinical Trials
Multiple myeloma treatment is advancing with the advent of bispecific antibody drugs, which use the patient’s T cells to fight the disease. Myeloma Center physicians and researchers Carolina Schinke, M.D., and Samer Al Hadidi, M.D., M.S., are leading clinical trials exploring combinations of these novel therapies. Schinke’s trial is studying the effects of using teclistamab…
March 13, 2025
UAMS Joins NIH Effort to Increase Rural Health Research
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has joined a network of institutions funded by the National Institutes of Health (NIH) to expand research in rural primary care clinics. Through the NIH CARE for Health™ initiative, UAMS will help lead innovative research to address health disparities in Arkansas’ rural areas. UAMS,…
March 12, 2025
UAMS Doctor Receives VA Merit Award to Address Overprescribing of Thyroid Medication
UAMS’ Spyridoula Maraka, M.D., has been awarded a Veterans Affairs (VA) Merit Award of $830,000 over four years to address the widespread overprescribing of levothyroxine (LT4), one of the most prescribed drugs in the United States. LT4 is used to treat hypothyroidism, a condition where the thyroid produces too few hormones. However, many patients are…
February 19, 2025
Three UAMS Researchers Awarded BioVentures LLC Accelerator Grants
BioVentures LLC at the University of Arkansas for Medical Sciences (UAMS) has announced three researchers as recipients of grants from the 2025 AR Health Ventures Accelerator (ARHVA), a program that supports the development of innovative drugs, diagnostics and devices. The 2025 grant recipients are: John Arthur, M.D., Ph.D., a professor and chief of the Division…
February 14, 2025
Arkansas Center for Birth Defects Research and Prevention Highlighted at Research Showcase
The Arkansas Center for Birth Defects Research and Prevention took center stage in the University of Arkansas for Medical Sciences (UAMS) Division of Research and Innovation’s latest Showcase of Medical Discoveries. The center in the UAMS Fay W. Boozman College of Public Health aims to understand the causes of birth defects and to reduce the…
February 12, 2025
How Geoffrey Curran, Ph.D., Forged a National Implementation Science Hub at UAMS
In biomedical research, some leaders not only advance their field but also build communities around it. Geoffrey Curran, Ph.D., is one such leader. Since joining the University of Arkansas for Medical Sciences (UAMS) in 1999, his name has become synonymous with implementation science, not just within Arkansas, but across the globe. Curran’s journey into implementation…
January 16, 2025
Eric Peterson, Ph.D., Named President of BioVentures LLC
LITTLE ROCK — Eric Peterson, Ph.D., has been named president of BioVentures LLC at the University of Arkansas for Medical Sciences (UAMS), a position he has held on an interim basis since March 2024. BioVentures, founded in 1994, is the technology licensing office and business incubator at UAMS, supporting the promotion, commercialization and development of…
January 8, 2025
UAMS Researcher Studies Impact of Physical Activity on Dementia Patients
Yong-Moon Mark Park, M.D., Ph.D., of the University of Arkansas for Medical Sciences (UAMS) led a study that looked at whether physical activity could lengthen the life expectancy for patients with dementia. “Our goal was to evaluate whether changes in physical activity levels before and after a dementia diagnosis could influence survival outcomes in individuals…
Previous page Next page